Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-02-20 @ 4:46 PM
Study NCT ID:
NCT02344602
Status:
COMPLETED
Last Update Posted:
2018-01-16
First Post:
2015-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effect of Uric Acid Lowering in Type 1 Diabetes
Sponsor:
University Health Network, Toronto
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Type 1 Diabetes Mellitus | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Diabetic Nephropathy | View |
| None | Diabetes Mellitus | View |
| None | Diabetes Complications | View |
| None | Uric Acid | View |
| None | Febuxostat | View |
| None | Uloric | View |
| None | Glomerular Filtration Rate | View |
| None | Kidney Disease | View |
| None | Vascular Disease | View |
| None | Cardiovascular Diseases | View |
| None | Endothelial Function | View |
| None | Arterial Stiffness | View |
| None | Pharmacologic Actions | View |
| None | Gout Suppressants | View |
| None | Therapeutic Uses | View |
| None | Free Radical Scavengers | View |
| None | Antioxidants | View |
| None | Protective Agents | View |
| None | Physiological Effects of Drugs | View |
| None | Angiotensin II Infusion | View |
| None | Flow-mediated Dilation | View |
| None | Flow-mediated Constriction | View |
| None | Nitroglycerin | View |
| None | Hyperglycemia | View |
| None | Renin-angiotensin-aldosterone System | View |
| None | Nitric Oxide | View |
| None | cGMP | View |
| None | Oxidative Stress | View |
| None | Renal Haemodynamic Function | View |
| None | Inulin Clearance | View |
| None | PAH Clearance | View |
| None | Skin Biopsy | View |
| None | T1R mRNA Expression | View |
| None | Cytokines | View |
| None | Chemokines | View |